Abstract
Mycobacterium w is a non-pathogenic, saprophytic, atypical mycobacterium with the ability to produce macrophage activating factors from lymphocytes of human patients. Prior immunization with heat-killed suspension of Mycobacterium w shows protection against sub-lethal infection with Mycobacterium tuberculosis H37Rv in mice. Heatkilled Mycobacterium w vaccine is manufactured by M/s Cadila Pharmaceuticals, Ahmedabad, India. Combined heatkilled M. w vaccine and multidrug treatment (MDT) revealed clinical, histological and bacteriological improvements in highly bacillated untreated anergic lepromatous cases of leprosy. In healthy contacts of leprosy patients, M. w vaccine has shown lepromin conversion and protection against leprosy. Only a few clinical studies have been carried out using antituberculous treatment with and without M. w vaccine in pulmonary tuberculosis, in which faster sputum conversion and higher cure rate have been observed in M. w group. M. w vaccine has shown potential of Tuberculin conversion in HIV positive subjects. In a study, five monthly doses of M. w vaccine have shown highly significant increase in CD4 count in HIV positive human beings. More clinical trials are needed to confirm beneficial role of M. w vaccine as an immunomodulator in therapy and prevention of tuberculosis, particularly so in multidrug resistant tuberculosis and those with HIV infection.
Keywords: Mycobacterium w, immunomodulator, tuberculosis, leprosy, immunoprophylaxis, immunotherapy
Current Respiratory Medicine Reviews
Title: Potential Utility of Mycobacterium w Vaccine in Control of Tuberculosis
Volume: 2 Issue: 2
Author(s): Murli L. Mathur
Affiliation:
Keywords: Mycobacterium w, immunomodulator, tuberculosis, leprosy, immunoprophylaxis, immunotherapy
Abstract: Mycobacterium w is a non-pathogenic, saprophytic, atypical mycobacterium with the ability to produce macrophage activating factors from lymphocytes of human patients. Prior immunization with heat-killed suspension of Mycobacterium w shows protection against sub-lethal infection with Mycobacterium tuberculosis H37Rv in mice. Heatkilled Mycobacterium w vaccine is manufactured by M/s Cadila Pharmaceuticals, Ahmedabad, India. Combined heatkilled M. w vaccine and multidrug treatment (MDT) revealed clinical, histological and bacteriological improvements in highly bacillated untreated anergic lepromatous cases of leprosy. In healthy contacts of leprosy patients, M. w vaccine has shown lepromin conversion and protection against leprosy. Only a few clinical studies have been carried out using antituberculous treatment with and without M. w vaccine in pulmonary tuberculosis, in which faster sputum conversion and higher cure rate have been observed in M. w group. M. w vaccine has shown potential of Tuberculin conversion in HIV positive subjects. In a study, five monthly doses of M. w vaccine have shown highly significant increase in CD4 count in HIV positive human beings. More clinical trials are needed to confirm beneficial role of M. w vaccine as an immunomodulator in therapy and prevention of tuberculosis, particularly so in multidrug resistant tuberculosis and those with HIV infection.
Export Options
About this article
Cite this article as:
Mathur L. Murli, Potential Utility of Mycobacterium w Vaccine in Control of Tuberculosis, Current Respiratory Medicine Reviews 2006; 2 (2) . https://dx.doi.org/10.2174/157339806776843120
DOI https://dx.doi.org/10.2174/157339806776843120 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
A Perspective on Monoamine Oxidase Enzyme as Drug Target: Challenges and Opportunities
Current Drug Targets Melatonin, Autophagy and Intestinal Bowel Disease
Current Pharmaceutical Design Editorial (Thematic Issue: Recent Trends in Library Design and Virtual Screening in Medicinal Chemistry and Drug Discovery)
Current Topics in Medicinal Chemistry Advancement in Microbial Cheminformatics
Current Topics in Medicinal Chemistry Targeting Cancer: The Challenges and Successes of Structure-Based Drug Design Against the Human Purinome
Current Topics in Medicinal Chemistry Pulmonary Infections in the Era of Biological Agents
Current Respiratory Medicine Reviews NKT Cell Subsets Can Exert Opposing Effects in Autoimmunity, Tumor Surveillance and Inflammation
Current Immunology Reviews (Discontinued) Toll-Like Receptors: Role in Inflammation and Commensal Bacteria
Inflammation & Allergy - Drug Targets (Discontinued) Metal Oxide Nanomaterials in Nanomedicine: Applications in Photodynamic Therapy and Potential Toxicity
Current Topics in Medicinal Chemistry Enhanced Oral Absorption of All-trans Retinoic Acid upon Encapsulation in Solid Lipid Nanoparticles
Pharmaceutical Nanotechnology Pyrimidine Salvage Pathway in Mycobacterium tuberculosis
Current Medicinal Chemistry Correlates of Patient Retention in HIV Care and Treatment Programs in Nigeria
Current HIV Research In Silico Discovery and Virtual Screening of Multi-Target Inhibitors for Proteins in Mycobacterium tuberculosis
Combinatorial Chemistry & High Throughput Screening A Review of Molecular Modelling Studies of Dihydrofolate Reductase Inhibitors Against Opportunistic Microorganisms and Comprehensive Evaluation of New Models
Current Pharmaceutical Design Induced Folding Under Membrane Mimetic and Acidic Conditions Implies Undiscovered Biological Roles of Prokaryotic Ubiquitin-Like Protein Pup
Protein & Peptide Letters Surfactant Protein A - From Genes to Human Lung Diseases
Current Medicinal Chemistry Metal Complexes, their Cellular Targets and Potential for Cancer Therapy
Current Pharmaceutical Design Recent Advances in Methodologies for the Discovery of Antimycobacterial Drugs
Current Bioactive Compounds Immune Monitoring to Predict the Development of Infections After Immunosuppression for Solid Organ Transplantation and Autoimmune Diseases
Current Drug Safety Dysprosium Hydroxide Nanowires Modified Electrode for Determination of Rifampicin Drug in Human Urine and Capsules by Adsorptive Square Wave Voltammetry
Current Pharmaceutical Analysis